| Literature DB >> 31249257 |
Fang Shen1, Chong-Shun Zhao1, Mei-Fen Shen2, Zhong Wang1, Gang Chen1.
Abstract
Gastrointestinal disease is a major global threat to public health. In the past few decades, numerous studies have focuses on the application of small molecule gases in the disease treatment. Increasing evidence has shown that hydrogen sulfide (H2S) has anti-inflammatory and anti-oxidative effects, and can regulate gastric mucosal blood flow in the gastric mucosa. After gastric mucosa damage, the level of H2S in the stomach decreases. Administration of H2S can protect and repair the damaged gastric mucosa. Therefore, H2S is a new target for the repair and treatment of gastric mucosa damage. In this review, we introduce the roles of H2S in the treatment of gastric mucosa damage and provide the potential strategies for further clinical treatment.Entities:
Keywords: anti-inflammation; anti-oxidation; carbon monoxide; experimental study; gastric mucosa; gastric mucosal blood flow; hydrogen sulfide; nitric oxide; protective effects
Mesh:
Substances:
Year: 2019 PMID: 31249257 PMCID: PMC6607860 DOI: 10.4103/2045-9912.260650
Source DB: PubMed Journal: Med Gas Res ISSN: 2045-9912
The effects of H2S in gastric mucosa damage
| Study | Model | Animals/cells | Main results |
|---|---|---|---|
| Aboubakr et al. | CRS | Rats | NaHS (60 μmol/kg, intraperitoneal injection) reduced the serum level of TNF-α and myeloperoxidase activity, and abrogated the inflammatory and the deleterious responses of gastric mucosa in CRS. |
| Guo et al. | Ischemic eperfusion | Human gastric epithelial cell | H2S exerted its protective effect through reactive oxygen species clearance, inhibition of p38 and JNK dependent cell apoptosis and NF-κB dependent inflammation pathway. |
| Magierowski et al. | Acetic acid | Rats | NaHS (10 mg/kg, intragastric administration) significantly decreased ulcer area and increased GBF at ulcer margin. |
| Magierowski et al. | NSAIDs | Rats | NaHS (5 mg/kg, intragastric administration) could raise mRNA or protein expression for CSE, COX-1 and decreased mRNA expression for IL-1β level in blood. |
| Magierowski et al. | WRS | Rats | NaHS dose-dependently attenuated severity of WRS-induced gastric lesions, increased GBF and improve gastric microcirculation. |
| Medeiros et al. | Ethanol | Mice | NaHS and Lawesson’s reagent (donors of H2S) decreased hemorrhagic damage, edema and epithelial cell loss. |
| Sun et al. | WRS | Rats | H2S played a protective role against WRS-induced gastric mucosal injury in rats, possibly through modulation of K+ATP channel opening and through the NF-κB dependent pathway. |
Note: H2S: Hydrogen sulfide; CRS: cold restraint stress; NaHS: sodium hydrosulfide; TNF-α: tumor necrosis factor-α; GBF: gastric blood flow; NSAIDs: non-steroidal anti-inflammatory drugs; CSE: cystathionine-γ-lyase; COX-1: cyclooxygenase-1; IL-1β: interleukin-1β; WRS: water immersion and restraint stress; JNK: c-Jun N-terminal kinase; NF-κB: nuclear factor-κB; K+ATP: ATP-sensitive potassium.